210 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Article Searches
Tesaro (TSRO) Presents At Bank of America Merrill Lynch 2018 Healthcare Conference - Slideshow https://seekingalpha.com/article/4174702-tesaro-tsro-presents-bank-america-merrill-lynch-2018-healthcare-conference-slideshow?source=feed_sector_healthcare May 16, 2018 - The following slide deck was published by Tesaro in conjunction with this event.
Clovis May 2018 Update https://seekingalpha.com/article/4174564-clovis-may-2018-update?source=feed_sector_healthcare May 16, 2018 - Positive CHMP opinion on European approval.Approval in expanded label in USA.A 'bottoming out' of the stock.Comparison of PARPi sales.Maintaining our position in Clovis.
Clovis (CLVS) Q1 Loss Wider Than Expected, Revenues Beat http://www.zacks.com/stock/news/302979/clovis-clvs-q1-loss-wider-than-expected-revenues-beat?cid=CS-ZC-FT-302979 May 09, 2018 - Clovis (CLVS) witnesses wider year-over-year loss in the first quarter. However, the company's revenues beat estimates. Rubraca sales increase.
Bb Biotech Ag Buys Tesaro Inc, argenx SE, Akcea Therapeutics Inc, Sells Juno Therapeutics Inc http://www.gurufocus.com/news/678810/bb-biotech-ag-buys-tesaro-inc-argenx-se-akcea-therapeutics-inc-sells-juno-therapeutics-inc May 08, 2018 - Bb Biotech Ag Buys Tesaro Inc, argenx SE, Akcea Therapeutics Inc, Sells Juno Therapeutics Inc, Stocks: TSRO,AKCA,REGN,VYGR,ARGX,JUNO,, release date:May 08, 2018
TSRO: Lake Street reits Buy http://www.briefing.com/investor/popuppages/articlepopup.aspx?articleId=UD20180507084551 May 07, 2018 - Lake Street issues rating change for TSRO
Tesaro 2018 Q1 - Results - Earnings Call Slides https://seekingalpha.com/article/4169893-tesaro-2018-q1-results-earnings-call-slides?source=feed_sector_healthcare May 04, 2018 - The following slide deck was published by Tesaro in conjunction with their 2018 Q1 earnings call.
TESARO's (TSRO) CEO Lonnie Moulder on Q1 2018 Results - Earnings Call Transcript https://seekingalpha.com/article/4169643-tesaros-tsro-ceo-lonnie-moulder-q1-2018-results-earnings-call-transcript?source=feed_sector_healthcare May 03, 2018 - TESARO Inc. (NASDAQ:TSRO) Q1 2018 Earnings Conference Call May 03, 2018 4:15 PM ET Executives Jennifer Davis – Vice President-Investor Relations and Corporate Communications Lonnie Moulder – Chief Exe
3 Things In Biotech, April 26: Taking The Bad With The Good https://seekingalpha.com/article/4166627-3-things-biotech-april-26-taking-bad-good?source=feed_sector_healthcare Apr 27, 2018 - AstraZeneca takes yet another hit in lung cancer immunotherapy.Tesaro's Zejula draws a new watermark for ovarian cancer.AveXis provides a glimpse into their pivotal trial in spinal muscular atrophy.
Your Daily Pharma Scoop: Alder's Migraine Data, Centene Revenues, Tesaro's Positive Results https://seekingalpha.com/article/4165436-daily-pharma-scoop-alders-migraine-data-centene-revenues-tesaros-positive-results?source=feed_sector_healthcare Apr 25, 2018 - Alder Biopharmaceuticals presented positive late-stage trial data.Centene reported outstanding Q1 revenues.Tesaro reports positive results from late-stage study of niraparib in ovarian cancer.
Tesaro: Time To Buy https://seekingalpha.com/article/4162838-tesaro-time-buy?source=feed_sector_healthcare Apr 13, 2018 - Tesaro’s valuation is now on par with that of Clovis.Tesaro is pursuing a broad development program for niraparib in ovarian cancer, which, if executed appropriately, will provide significant competit

Pages: 123456...21

Page 1>
DeepLinks for TESARO
TSRO - Google Finance https://www.google.com/finance?q=TSRO Industry related info and international coverage Summary News
TSRO - Bloomberg http://www.bloomberg.com/research/stocks/snapshot/snapshot.asp?ticker=TSRO Original news and commentary from Bloomberg Charts Financials with pensions Snapshot Earnings Transactions People Options